Joltoo
InvestorsInsights
DeepTech 2026 Playbook
Browse all
  1. Home
  2. /Investors
  3. /Biotech
  4. /Sofinnova Partners
Sofinnova Partners

Sofinnova Partners

DeepTech NativeParis, FranceActiveWebsite
Stage FocusSeed, Series A, Series B+
GeographyEurope, US
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedTechClimate Tech
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio

Sofinnova Partners was founded in 1972 in Paris, making it one of the oldest and most established life sciences VCs in Europe. The firm recently raised approximately €1.5B across Capital XI (€650M) and Biovelocita II (€165M), investing from seed to growth across biotech, medtech, and sustainability.

The portfolio spans 500+ companies over five decades, including Actelion, Genfit, Poxel, Valneva, ...

Notable Investments
A
Actelion
G
Genfit
P
Poxel
V
Valneva
D
DBV Technologies

Similar Funds

Abingworth

Abingworth

London, United Kingdom

DeepTech NativeBiotechMedTechSeedSeries A
Brandon Capital

Brandon Capital

Melbourne, Australia

DeepTech NativeBiotechMedTechSeedSeries A
Leaps by Bayer

Leaps by Bayer

Leverkusen, Germany

DeepTech NativeBiotechAgriTechMedTechSeedSeries A
M Ventures (Merck)

M Ventures (Merck)

Amsterdam, Netherlands

DeepTech NativeBiotechSemiconductorsAdvanced MaterialsSeedSeries A
MPM Capital

MPM Capital

Boston, United States

DeepTech NativeBiotechMedTechSeedSeries A
Osage University Partners

Osage University Partners

Bala Cynwyd, United States

DeepTech NativeBiotechMedTechClimate TechSeedSeries A
Joltoo
Privacy PolicyTerms of Service
© 2026 Joltoo. All rights reserved.